JP2022513339A5 - - Google Patents
Info
- Publication number
- JP2022513339A5 JP2022513339A5 JP2021543981A JP2021543981A JP2022513339A5 JP 2022513339 A5 JP2022513339 A5 JP 2022513339A5 JP 2021543981 A JP2021543981 A JP 2021543981A JP 2021543981 A JP2021543981 A JP 2021543981A JP 2022513339 A5 JP2022513339 A5 JP 2022513339A5
- Authority
- JP
- Japan
- Prior art keywords
- expression construct
- artificial expression
- injection
- seq
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024187194A JP7829658B2 (ja) | 2018-10-08 | 2024-10-24 | 介在ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862742835P | 2018-10-08 | 2018-10-08 | |
| US62/742,835 | 2018-10-08 | ||
| US201862749012P | 2018-10-22 | 2018-10-22 | |
| US62/749,012 | 2018-10-22 | ||
| US201962810281P | 2019-02-25 | 2019-02-25 | |
| US62/810,281 | 2019-02-25 | ||
| PCT/US2019/054539 WO2020076614A1 (en) | 2018-10-08 | 2019-10-03 | Artificial expression constructs for selectively modulating gene expression in interneurons |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024187194A Division JP7829658B2 (ja) | 2018-10-08 | 2024-10-24 | 介在ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022513339A JP2022513339A (ja) | 2022-02-07 |
| JP2022513339A5 true JP2022513339A5 (https=) | 2022-10-11 |
| JP7695192B2 JP7695192B2 (ja) | 2025-06-18 |
Family
ID=70164665
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543981A Active JP7695192B2 (ja) | 2018-10-08 | 2019-10-03 | 介在ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物 |
| JP2024187194A Active JP7829658B2 (ja) | 2018-10-08 | 2024-10-24 | 介在ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024187194A Active JP7829658B2 (ja) | 2018-10-08 | 2024-10-24 | 介在ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12467064B2 (https=) |
| EP (1) | EP3864150A4 (https=) |
| JP (2) | JP7695192B2 (https=) |
| AU (2) | AU2019358806B2 (https=) |
| CA (1) | CA3115652A1 (https=) |
| WO (1) | WO2020076614A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3096407A1 (en) | 2018-04-09 | 2019-10-17 | Allen Institute | Rescuing voltage-gated sodium channel function in inhibitory neurons |
| WO2020076614A1 (en) * | 2018-10-08 | 2020-04-16 | Allen Institute | Artificial expression constructs for selectively modulating gene expression in interneurons |
| AU2021261359A1 (en) * | 2020-04-21 | 2022-12-08 | Allen Institute | Artificial expression constructs for selectively modulating gene expression in neocortical layer 5 glutamatergic neurons |
| JP7767324B2 (ja) * | 2020-06-04 | 2025-11-11 | アレン インスティテュート | 抑制性新皮質ニューロンにおいて遺伝子発現を選択的に調節する人工発現構築物 |
| WO2022036255A1 (en) * | 2020-08-14 | 2022-02-17 | Allen Institute | Artificial expression constructs for modulating gene expression in striatal neurons |
| GB202013940D0 (en) | 2020-09-04 | 2020-10-21 | Synpromics Ltd | Regulatory nucleic acid sequences |
| AU2022217778A1 (en) * | 2021-02-02 | 2023-08-31 | Allen Institute | Artificial expression constructs for modulating gene expression in gabaergic neurons and astrocytes |
| CN116286917A (zh) * | 2021-12-14 | 2023-06-23 | 中国科学院深圳先进技术研究院 | 重组载体及其构建方法和应用 |
| JP2025520385A (ja) * | 2022-06-13 | 2025-07-03 | アレン インスティテュート | 中枢神経系の非神経細胞において遺伝子発現を調節するための人工発現コンストラクト |
| CN119403933A (zh) * | 2022-06-21 | 2025-02-07 | 里格尔医疗股份有限公司 | 遗传调控元件及其用途 |
| CN119060958A (zh) * | 2023-12-15 | 2024-12-03 | 中国科学院深圳先进技术研究院 | 一种携带钙离子报告基因的神经元及其制备方法和应用 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2002A (en) | 1841-03-12 | Tor and planter for plowing | ||
| US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
| US5252334A (en) | 1989-09-08 | 1993-10-12 | Cygnus Therapeutic Systems | Solid matrix system for transdermal drug delivery |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| US5851832A (en) | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
| US5766948A (en) | 1993-01-06 | 1998-06-16 | The Regents Of The University Of California | Method for production of neuroblasts |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| US6001654A (en) | 1994-01-28 | 1999-12-14 | California Institute Of Technology | Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors |
| US5697899A (en) | 1995-02-07 | 1997-12-16 | Gensia | Feedback controlled drug delivery system |
| IE80468B1 (en) | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
| US6048964A (en) | 1995-12-12 | 2000-04-11 | Stryker Corporation | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| US5656016A (en) | 1996-03-18 | 1997-08-12 | Abbott Laboratories | Sonophoretic drug delivery system |
| US5753506A (en) | 1996-05-23 | 1998-05-19 | Cns Stem Cell Technology, Inc. | Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals |
| US5797898A (en) | 1996-07-02 | 1998-08-25 | Massachusetts Institute Of Technology | Microchip drug delivery devices |
| US5783208A (en) | 1996-07-19 | 1998-07-21 | Theratech, Inc. | Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| US5779708A (en) | 1996-08-15 | 1998-07-14 | Cyberdent, Inc. | Intraosseous drug delivery device and method |
| US5968829A (en) | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
| AU3642601A (en) * | 1999-11-05 | 2001-05-30 | Avigen, Inc. | Ecdysone-inducible adeno-associated virus expression vectors |
| US6395546B1 (en) | 2000-02-01 | 2002-05-28 | Neurogeneration, Inc. | Generation of dopaminergic neurons from human nervous system stem cells |
| EP1360310A2 (en) | 2001-02-13 | 2003-11-12 | University Of Florida | A bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes |
| ATE541921T1 (de) | 2001-09-14 | 2012-02-15 | Stem Cell Therapeutics Inc | Prolaktin-induzierte zunahme an neuronalen stammzellen und dessen therapeutische anwendung |
| CA2474751A1 (en) | 2002-02-25 | 2003-09-04 | Vanderbilt University | Expression system for human brain-specific voltage-gated sodium channel, type 1 |
| EP2176283B1 (en) | 2007-07-14 | 2016-11-02 | University of Iowa Research Foundation | Methods and compositions for treating brain diseases |
| US20120308530A1 (en) | 2011-06-03 | 2012-12-06 | Beijing Allgens Medical Science & Technology Co., Ltd. | Materials Composition and Methods to Control Neural Progenitor and Stem Cell Attachment, Proliferation and Guide Cell Differentiation |
| US20150044667A1 (en) | 2012-03-20 | 2015-02-12 | The Trustees Of The University Of Pennsylvania | Human papillomavirus 16 (hpv16) - related epilepsy |
| WO2014033095A1 (en) | 2012-08-27 | 2014-03-06 | Friedrich Miescher Institute For Biomedical Research | Retinal off circuit-specific promoter |
| DE102014207498A1 (de) | 2014-04-17 | 2015-10-22 | Universitätsklinikum Hamburg-Eppendorf | Viraler Vektor für den zielgerichteten Gentransfer in Gehirn und Rückenmark |
| US10682424B2 (en) * | 2015-03-31 | 2020-06-16 | New York University | Compositions and method for reducing seizures |
| DK3081263T3 (da) | 2015-04-17 | 2020-03-16 | P&X Medical Nv | Sammensætninger og redskaber til behandling af glaukom |
| BR112017024514A2 (pt) | 2015-05-16 | 2018-07-24 | Genzyme Corporation | edição genética de mutações intrônicas profundas |
| KR102423442B1 (ko) | 2015-12-11 | 2022-07-20 | 캘리포니아 인스티튜트 오브 테크놀로지 | 아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드 |
| MX2019011772A (es) * | 2017-04-03 | 2020-01-09 | Encoded Therapeutics Inc | Expresion transgenica selectiva de tejidos. |
| US11980671B2 (en) | 2017-07-26 | 2024-05-14 | Duke University | Use of bacterial voltage gated ion channels for human therapies |
| CA3096407A1 (en) | 2018-04-09 | 2019-10-17 | Allen Institute | Rescuing voltage-gated sodium channel function in inhibitory neurons |
| WO2020076614A1 (en) * | 2018-10-08 | 2020-04-16 | Allen Institute | Artificial expression constructs for selectively modulating gene expression in interneurons |
-
2019
- 2019-10-03 WO PCT/US2019/054539 patent/WO2020076614A1/en not_active Ceased
- 2019-10-03 EP EP19870829.9A patent/EP3864150A4/en active Pending
- 2019-10-03 CA CA3115652A patent/CA3115652A1/en active Pending
- 2019-10-03 AU AU2019358806A patent/AU2019358806B2/en active Active
- 2019-10-03 US US17/283,232 patent/US12467064B2/en active Active
- 2019-10-03 JP JP2021543981A patent/JP7695192B2/ja active Active
-
2024
- 2024-10-24 JP JP2024187194A patent/JP7829658B2/ja active Active
- 2024-12-31 US US19/007,152 patent/US20250223612A1/en active Pending
-
2025
- 2025-07-25 AU AU2025208516A patent/AU2025208516A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022513339A5 (https=) | ||
| JP2025023947A5 (https=) | ||
| ES2223051T3 (es) | Vectores de adnc de alfavirus. | |
| US20190315642A1 (en) | Compositions for in vivo Expression of Therapeutic Sequences in the Microbiome | |
| CN102741405B (zh) | 提高基因表达的系统和保持有该系统的载体 | |
| JP2026021360A5 (https=) | ||
| EP4051694B1 (en) | Aav vector variants for ocular gene delivery | |
| CN112040988A (zh) | 修饰的aav衣壳多肽用于治疗肌肉疾病 | |
| US20230048025A1 (en) | Adeno associated viral vectors | |
| RU2018120736A (ru) | Нацеливающие пептиды для направленной доставки аденоассоциированных вирусов (aav) | |
| CA2382832A1 (en) | Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna | |
| CN113301956B (zh) | 控制器官功能的基因治疗方法 | |
| US20160367701A1 (en) | Compositions for in vivo Expression of Therapeutic Sequences in the Microbiome | |
| CN114072179A (zh) | 肌球蛋白15启动子及其用途 | |
| US12472270B2 (en) | Methods and compositions for reprogramming Müller Glia | |
| JP2024505027A5 (https=) | ||
| Grinevich et al. | Somatic transgenesis (viral vectors) | |
| JP2024519955A5 (https=) | ||
| JP2023529833A5 (https=) | ||
| CN113121654A (zh) | 新型腺相关病毒衣壳蛋白及包含其的新型腺相关病毒载体 | |
| CN115975053B (zh) | 靶向新型冠状病毒的疫苗 | |
| US11701437B2 (en) | Systemic delivery of polypeptides | |
| CN112961220A (zh) | 新型腺相关病毒衣壳蛋白及包含其的新型腺相关病毒载体 | |
| EP4361278A1 (en) | Composition and method for treating hemophilia b | |
| RU2828544C1 (ru) | Препарат для стимулирования регенерации и нейропротекции нервной ткани и способ его использования |